454 Life Sciences, now part of Roche Diagnostics, and researchers from the Baylor College of Medicine (BCM) in Houston, US will present James Watson, co-discoverer of the DNA double helix and developer of the human genome project with his personal genome DNA sequence data at on May 31.
Biobase has joined the Affymetrix GeneChip compatible applications program and announced that its ExPlain Analysis System and TRANSFAC database have achieved GeneChip compatible status.
"Affymetrix is pleased to welcome Biobase to the family of GeneChip-compatible software providers," said Steve Lincoln, vice president of Informatics at Affymetrix.
"The coupling of the rich content of TRANSFAC with the analytical methods in ExPlain can result in a greater understanding of disease states and their associated biological processes to users of GeneChip microarrays."
Guava Technologies has established a European office in Stamford, UK, that will focus on growing its business in Europe, the Middle East and Africa.
"Guava Technologies has grown significantly since it was founded in 1998, and continues to deliver innovative technologies for cell analysis to an ever-increasing number of research scientists and clinicians across numerous disciplines, including immunology, oncology, virology, and drug discovery," said Lawrence Bruder, CEO of Guava Technologies.
The Max Planck Society's technology transfer agency, Max Planck Innovation, has signed a co-exclusive license with Leica Microsystems and Carl Zeiss MicroImaging for its reversible saturable optical fluorescent transitions technology (RESOLFT) that provides molecular scale resolution with visible light and regular lenses for use in microscopy.
The technology enables researchers to observe molecular dye structures at the 1 or 2 nm resolution inside living cells and viruses without destroying the samples.
"We are excited about the potential of RESOLFT as an important tool for biological research," stated Dr. Martin Haase, general manager of Leica Microsystems' Life Science Research Division.
"We are confident that the RESOLFT method will open new avenues for research experiments leading to groundbreaking new results in a similar way as STED (Stimulated Emission Depletion)."
Carl Zeiss MicroImaging has also licensed the Coherent anti-Stokes Raman scattering (CARS) microscopy technology from Harvard University's Office of Technology Development.
The technology was developed by Professor Xialiang Sunney, and allows the rapid imaging of biological specimens by tuning into the intrinsic vibrations of specific molecules.
Whatman has agreed a non-exclusive license with diagnostic products maker Qiagen for its FTA product line, allowing Qiagen to sell the DNA collection, transportation and storage products to its customers.
Qiagen will pay an initial fee for the non-exclusive distribution rights, as well as royalties on the sale of all products that incorporate the FTA technology.
GE Healthcare plans to open a factory to make diagnostic imaging systems in Saudi Arabia, which will be its first plant in the Middle East.
The move highlights General Electric Company's growing focus on the developing world where it expects to generate 60 per cent of its growth over the next decade.
